Meta-analysis of the overall treatment-related adverse events associated with pembrolizumab.


<p>Subgroup analysis of patients treated with different doses of pembrolizumab revealed a dose-dependent increase in adverse events.</p

Similar works

Full text

oai:figshare.com:article/3510895Last time updated on 2/12/2018

This paper was published in FigShare.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.